Xenon Pharmaceuticals Inc (XENE)

XENE's social dominance surges amid mixed sentiment, with recent posts highlighting upcoming Phase [--] readouts and potential Airdrop updates.

About Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders.
Xenon Pharmaceuticals Inc uses the ticker $XENE for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Xenon Pharmaceuticals Inc (XENE) social dominance hit [------] which is 120% higher than it's daily average.
Xenon Pharmaceuticals Inc (XENE) social dominance is up 215.52% from the previous [--] months.
Xenon Pharmaceuticals Inc (XENE) creators is up 78.57% from the previous week.
Xenon Pharmaceuticals Inc (XENE) engagements is up 115.86% from the previous week.
Xenon Pharmaceuticals Inc (XENE) mentions is up 44.54% from the previous week.
Xenon Pharmaceuticals Inc (XENE) posts created is up 23.08% from the previous week.

Price: $41.50

Price 24-Hour Time-Series Raw Data
Despite reaching a 52-week high, XENE's price has declined due to negative sentiment and reduced social engagement, which have outweighed positive study data and portfolio inclusion mentions.

24-Hour: -0.81% 7-Day: -2.24% 30-Day: 3.75%

1-Year High: $46.10 on 2025-12-22
1-Year Low: $28.20 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Xenon Pharmaceuticals Inc (XENE) is currently AltRank #428 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +526
[--] Months: [---] +238
[--] Year: [---] [----]
1-Year High: [-----] on 2025-07-27
1-Year Low: [--] on 2025-04-18

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +15
[--] Months: [--] +12
[--] Year: [--] +31
1-Year High: [--] on 2025-08-04
1-Year Low: [--] on 2025-08-28

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [------] +116%
[--] Month: [-------] +3.10%
[--] Months: [---------] -41%
[--] Year: [---------] -2.70%
1-Year High: [-------] on 2025-07-18
1-Year Low: [---] on 2026-01-04

Engagements by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [------]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +45%
[--] Month: [---] +33%
[--] Months: [-----] -35%
[--] Year: [-----] +52%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-27

Mentions by network (24h): News: [--] Reddit: [--] YouTube: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Xenon Pharmaceuticals Inc (XENE) in the last [--] hours which is down 13% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +79%
[--] Month: [---] +69%
[--] Months: [---] -68%
[--] Year: [-----] +44%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-24

The most influential creators that mention Xenon Pharmaceuticals Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@Andre_AGTC	[--]	[-----]	[--]	[-----]
@Biotech2k1	[--]	[------]	[--]	[---]
@BuyTheUgly	[--]	[--]	[--]	[--]
@inshatters1	[--]	[--]	[--]	[--]
@Mimer_updatee	[--]	[---]	[--]	[--]
@WolfOfPathogens	[--]	[--]	[--]	[--]
@DeepSouthDoctor	[--]	[-----]	[--]	[--]
@stocket_rocket	[--]	[--]	[--]	[--]
@mariostario2019	[--]	[--]	[--]	[--]

Sentiment: 88%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 88%
Daily Average: 84%
[--] Week: 67% -33%
[--] Month: 88% +6%
[--] Months: 88% +6%
[--] Year: 88% +26%
1-Year High: 100% on 2025-03-19
1-Year Low: 30% on 2025-04-29

Most Supportive Themes:

Seizure and Epilepsy Treatments: (50%) Xenon Pharmaceuticals Inc. is developing treatments for neurological disorders, specifically epilepsy and seizures.
Portfolio Inclusion: (30%) Investors are adding Xenon Pharmaceuticals Inc. to their portfolios, indicating confidence in its future prospects.
Strength Meter Maps: (20%) Xenon Pharmaceuticals Inc. is being mentioned in the context of strength meter maps, suggesting its performance is being tracked within broader market analyses.

Most Critical Themes:

Negative Sentiment and Declining Social Engagement: (100%) A prevailing negative sentiment and a decrease in social media engagement are identified as potential reasons for the recent stock price dip.

Social Dominance: 0.00488%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00488%
Daily Average: 0.00832%
[--] Week: 0.00475% +0.00125%
[--] Month: 0.018% +0.012%
[--] Months: 0.018% +0.0072%
[--] Year: 0.018% +0.011%
1-Year High: 0.035% on 2025-06-28
1-Year Low: 0.0021% on 2025-09-27

Market Dominance: 0.00363%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00363%
Daily Average: 0%
1-Year High: 0.096% on 2025-03-31
1-Year Low: 0.00297% on 2025-07-25

Market Cap: $3,205,367,207

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,205,367,207
Daily Average: $2,870,604,432
[--] Week: $3,205,367,207 -2.20%
[--] Month: $3,205,367,207 +3.80%
[--] Months: $3,205,367,207 +10%
[--] Year: $3,205,367,207 +8.10%
1-Year High: $3,560,832,230 on 2025-12-22
1-Year Low: $2,160,803,555 on 2025-04-08

Top Xenon Pharmaceuticals Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, 12.3K engagements

"🚨 Xenea Wallet Airdrop Update 🔔 💥Xenea Wallet is currently under maintenance. If the app isnt opening for the daily quiz its not a glitch. 🔴No official time for completion yet check back in a few hours. 🌀Maybe this update brings us closer to the $XENE TGE 👀"
X Link @rbhakta123 2026-02-15T13:29Z [---] followers, [---] engagements

"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"
X Link @BiopharmIQ 2026-02-14T16:03Z 28.9K followers, 11.6K engagements

"$CMPS MC 570M 6.5M diagnosed TRD pts / 3M in US TAM $6.7B+ by [----] $CMPS (COMP360) ph3 TRD data in Q1'26 NDA in H2'26 Single-dose durability vs. Spravato repeat dosing $JNJ Spravato 2019: FDA approval for TRD 2025: $1.7B revenue (blockbuster) 60% growth in q4 vs [----] @KingachillesE $CMPS will combine 9w data (Part A) and 26w data (Part B). Practically two readouts at once so it might take a bit longer But on the other side $XENE had a history running slower than expected so who knows Added to $CMPS at [----] today at close. Hope is not too early @KingachillesE $CMPS will combine 9w data (Part"
X Link @Andre_AGTC 2026-02-13T14:35Z [----] followers, 11.8K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing